We have an experienced leadership team that covers all relevant pharmaceutical development functions. Our team has a proven track record and has contributed to drug discovery and development as well as approval, launch, and commercialization of multiple specialty medicines.

Lynne Powell
Chief Executive Officer
Dr. Andreas Maetzel
Chief Medical Officer
Darren Brayton
Vice President, Technical Operations
Katalin Ferenczi
General Manager, Europe
Dr. Elizabeth Manning Duus
Vice President, Clinical Development
Marion McGlynn
Vice President, Project and portfolio management
Lester Szymanik
Head of Finance